Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”

In the article titled “HDR Brachytherapy in the Management of High-Risk Prostate Cancer” [1], there was an error in Table 2, which should be corrected as follows: For Hoskin et al. [32], the dose should read 35.75 Gy in 13 fractions EBRT, not 55 Gy in 20 fractions EBRT.

Saved in:
Bibliographic Details
Published in:Advances in urology 2016-01, Vol.2016 (2016), p.1-1
Main Authors: Masson, Susan, Bahl, Amit, Persad, Raj
Format: Article
Language:English
Subjects:
Corrigendum
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the article titled “HDR Brachytherapy in the Management of High-Risk Prostate Cancer” [1], there was an error in Table 2, which should be corrected as follows: For Hoskin et al. [32], the dose should read 35.75 Gy in 13 fractions EBRT, not 55 Gy in 20 fractions EBRT.
ISSN:1687-6369
1687-6377
DOI:10.1155/2016/6345816